GT Biopharma (GTBP) Goodwill & Intangibles (2010 - 2019)

GT Biopharma (GTBP) has reported Goodwill & Intangibles for 8 consecutive years, with $25.3 million the latest figure, recorded in Q2 2019.

• In Q2 2019, Goodwill & Intangibles fell 90.05% year-over-year to $25.3 million; the TTM figure through Jun 2019 stood at $25.3 million (down 90.05% YoY), while the FY2018 annual figure was $25.3 million, down 90.05% from the prior year.
• Goodwill & Intangibles held at $25.3 million in Q2 2019 per GTBP's latest filing, from $25.3 million in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $253.8 million in Q3 2017 and bottomed at $25.3 million in Q4 2018.
• Historically, Goodwill & Intangibles has averaged $139.5 million across 3 years, with a median of $139.5 million in 2017.
• On a YoY basis, Goodwill & Intangibles climbed as much as 90.05% in 2018 and fell as far as 90.05% in 2018.
• GT Biopharma's Goodwill & Intangibles stood at $253.8 million in 2017, then slumped by 90.05% to $25.3 million in 2018, then changed by 0.0% to $25.3 million in 2019.
• Business Quant data shows GTBP's Goodwill & Intangibles at $25.3 million in Q2 2019, $25.3 million in Q1 2019, and $25.3 million in Q4 2018.